Beijing Kawin Bio-Tech Co.,Ltd. |
|||||||||||||||||
|
|
|||||||||||||||||
| Beijing Kawin Bio-Tech Co., Ltd, also the National Engineering Research Center for Viral Bio-Technology ( the Engineering Center), was founded in Dec. 1999. It is located in Beijing Economic-Technological Development Area (BDA). The company occupies an area of 16,000 square meters. The registered capital of the company is $20.43 million. It has 170 staff members, the average age is 28. Beijing Kawin Bio-Tech is a specialized manufacturer in the field of bio-technology. Each set of equipments and facilities meet the FDA standard. All workshops have passed the China¡¯s GMP certification. The quality controlling system is composed of over 800 files. The product quality not only conform to the Requirements for Biologics of the People¡¯s Republic of China (2000 version), but also meet the BP requirements. Kawin¡¯s first major product is KAFERON¡ªa product of Recombinant Human Interferon ¦Ã-2b. KAFERON has three different specifications: 1MIU, 3MIU and 5MIU. Three drug forms: water injection in vial and in pre-filled syringe, lyophilized injection in vial. Other products include Pyritinol Hydrochloride for Injection and SAMe intermediaters. 5 kinds of chemical products will be produced within 2 years, namely are a. Ozagrel Sodium for Injection b. Thymopentin lyophilized injection c. Ganciclovir for injection d. Naloxone Hydrochloride Injection e. Tiopronin for Injection |
|||||||||||||||||
 |
|||||||||||||||||
|
|||||||||||||||||
|
|||||||||||||||||
|
|||||||||||||||||
|
| Home | Privacy
Statement | Terms
of Use | Advertising | Partners | Contact
Us | Help
Copyright 2001-2026, b2b-board.com. All Rights Reserved.
|